Search research articles
Contact Us
Filters
Showing results (131-140 of 214) with videos related to
Page
of 22
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 10, 2012
Hepatitis B and C virus infection among 1.2 million persons with access to care: factors associated with testing and infection prevalence
Philip R Spradling, Loralee Rupp, Anne C Moorman, et al.
Digestive Diseases and Sciences
|
October 2, 2017
A Point System to Forecast Hepatocellular Carcinoma Risk Before and After Treatment Among Persons with Chronic Hepatitis C
Jian Xing, Philip R Spradling, Anne C Moorman, et al.
Infectious Disease Clinics of North America
|
May 21, 2018
Long-Term Liver Disease, Treatment, and Mortality Outcomes Among 17,000 Persons Diagnosed with Chronic Hepatitis C Virus Infection: Current Chronic Hepatitis Cohort Study Status and Review of Findings
Anne C Moorman, Loralee B Rupp, Stuart C Gordon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 31, 2018
Mortality Among Patients With Chronic Hepatitis B Infection: The Chronic Hepatitis Cohort Study (CHeCS)
Danae Bixler, Yuna Zhong, Kathleen N Ly, et al.
Hepatology (Baltimore, Md.)
|
January 2, 2010
Efficacy of entecavir in chronic hepatitis B patients with mildly elevated alanine aminotransferase and biopsy-proven histological damage
I-Chin Wu, Ching-Lung Lai, Steven-Huy Bui Han, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 16, 2015
Grazoprevir, Elbasvir, and Ribavirin for Chronic Hepatitis C Virus Genotype 1 Infection After Failure of Pegylated Interferon and Ribavirin With an Earlier-Generation Protease Inhibitor: Final 24-Week Results From C-SALVAGE
Maria Buti, Stuart C Gordon, Eli Zuckerman, et al.
Alimentary Pharmacology & Therapeutics
|
June 30, 2020
Clinical assessment for high-risk patients with non-alcoholic fatty liver disease in primary care and diabetology practices
Zobair M Younossi, Kathleen E Corey, Naim Alkhouri, et al.
Journal of Hepatology
|
April 22, 2015
Grazoprevir and elbasvir plus ribavirin for chronic HCV genotype-1 infection after failure of combination therapy containing a direct-acting antiviral agent
Xavier Forns, Stuart C Gordon, Eli Zuckerman, et al.
Annals of Internal Medicine
|
April 16, 2003
Serum ferritin level predicts advanced hepatic fibrosis among U.S. patients with phenotypic hemochromatosis
Elizabeth D Morrison, David J Brandhagen, Pradyumna D Phatak, et al.
Hepatology (Baltimore, Md.)
|
August 19, 2014
Late diagnosis of hepatitis C virus infection in the Chronic Hepatitis Cohort Study (CHeCS): Missed opportunities for intervention
Anne C Moorman, Jian Xing, Stephen Ko, et al.
Page
of 22
Search research articles
Search
Showing results (131-140 of 214) with videos related to
Sort By:
Page
of 22
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 10, 2012
Hepatitis B and C virus infection among 1.2 million persons with access to care: factors associated with testing and infection prevalence
Philip R Spradling, Loralee Rupp, Anne C Moorman, et al.
Digestive Diseases and Sciences
|
October 2, 2017
A Point System to Forecast Hepatocellular Carcinoma Risk Before and After Treatment Among Persons with Chronic Hepatitis C
Jian Xing, Philip R Spradling, Anne C Moorman, et al.
Infectious Disease Clinics of North America
|
May 21, 2018
Long-Term Liver Disease, Treatment, and Mortality Outcomes Among 17,000 Persons Diagnosed with Chronic Hepatitis C Virus Infection: Current Chronic Hepatitis Cohort Study Status and Review of Findings
Anne C Moorman, Loralee B Rupp, Stuart C Gordon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 31, 2018
Mortality Among Patients With Chronic Hepatitis B Infection: The Chronic Hepatitis Cohort Study (CHeCS)
Danae Bixler, Yuna Zhong, Kathleen N Ly, et al.
Hepatology (Baltimore, Md.)
|
January 2, 2010
Efficacy of entecavir in chronic hepatitis B patients with mildly elevated alanine aminotransferase and biopsy-proven histological damage
I-Chin Wu, Ching-Lung Lai, Steven-Huy Bui Han, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 16, 2015
Grazoprevir, Elbasvir, and Ribavirin for Chronic Hepatitis C Virus Genotype 1 Infection After Failure of Pegylated Interferon and Ribavirin With an Earlier-Generation Protease Inhibitor: Final 24-Week Results From C-SALVAGE
Maria Buti, Stuart C Gordon, Eli Zuckerman, et al.
Alimentary Pharmacology & Therapeutics
|
June 30, 2020
Clinical assessment for high-risk patients with non-alcoholic fatty liver disease in primary care and diabetology practices
Zobair M Younossi, Kathleen E Corey, Naim Alkhouri, et al.
Journal of Hepatology
|
April 22, 2015
Grazoprevir and elbasvir plus ribavirin for chronic HCV genotype-1 infection after failure of combination therapy containing a direct-acting antiviral agent
Xavier Forns, Stuart C Gordon, Eli Zuckerman, et al.
Annals of Internal Medicine
|
April 16, 2003
Serum ferritin level predicts advanced hepatic fibrosis among U.S. patients with phenotypic hemochromatosis
Elizabeth D Morrison, David J Brandhagen, Pradyumna D Phatak, et al.
Hepatology (Baltimore, Md.)
|
August 19, 2014
Late diagnosis of hepatitis C virus infection in the Chronic Hepatitis Cohort Study (CHeCS): Missed opportunities for intervention
Anne C Moorman, Jian Xing, Stephen Ko, et al.
Page
of 22